AzTrials
AzTrials

Looking at the Effects of Krill Oil Supplementation on Recovery From Muscle-damaging ExerciseKORENCT06939244

Investigating the Effects of Krill Oil on the Recovery From Muscle Damaging Exercise: a Randomised Controlled Trial

A study testing Krill oil in people with Looking at the Effects of Krill Oil Supplementation on Recovery From Muscle-damaging Exercise, run by University of Glasgow at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

1. What will happen to me if I take part? All study visits will be at the University of Glasgow main campus within the Sir James Black building. Initial visit (duration 1 hours) We will ask that for each study visit you come to the laboratory with clothing suitable to exercise in (loose shorts) for your own comfort… Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
What is being tested?
Krill oil
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
32 participants
Where
1 siteUnited Kingdom
Study dates
1 Feb 2025to 1 Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Be 60 years old or older
  • Have a BMI of less than 30kg/m2
  • Participating in resistance-type exercise for less than 1h per week

Who cannot join

  • Diabetes
  • Severe cardiovascular disease defined as arrythmia, valve disease, coronary artery disease, heart failure, peripheral arterial disease, cerebrovascular disease, congenital heart disease or myocardial infarct.
  • Seizure disorders
  • Uncontrolled hypertension (blood pressure higher than 150/90mmHg at baseline measurement)
  • Cancer or cancer that has been in remission for less than 5 years
  • Ambulatory impairments limiting the ability to perform muscle function assessments
Show all 11Show fewer
  • Dementia
  • Taking medications known to affect muscle (like steroids)
  • Having an implanted electronic device (such as a pacemaker, defibrillator, or insulin pump)
  • Allergies to seafood
  • Regular consumption of more than one portion of oily fish per week

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United Kingdom1 site, 1 recruiting
  • University of Glasgow

    Glasgow, Other, G12 8TA

    Stuart Gray, 01413302569, stuart.gray@glasgow.ac.uk

    Recruiting

Other trials in United Kingdom

About this study

  1. What will happen to me if I take part?

All study visits will be at the University of Glasgow main campus within the Sir James Black building.

Read more

Initial visit (duration 1 hours)

We will ask that for each study visit you come to the laboratory with clothing suitable to exercise in (loose shorts) for your own comfort and to also make it easier for us to complete certain measurements where access to upper legs will be necessary. Changing facilitates will be provided on-site. After the screening process, your physical activity and your diet will be assessed via questionnaires. We will then familiarise you with the physical function tests and neuromuscular measurements.

Visit 2 (duration 1 hours)

Before the remaining study visits in the morning, you will be asked to arrive at the laboratory after an overnight fast (no food or caffeinated/calorific beverages from 10pm), and without having done intense exercise for two days prior to the visit. Upon arriving in the laboratory, we will collect a blood sample (after which we will provide you with a snack), and measure your body composition, muscle size, muscle strength and physical function. You will then be familiarised with the resistance training protocol, and we will determine your maximum strength for two leg exercises. After these measurements are completed, we will randomly assign you to consumed 2g/day of either krill oil or a mixed vegetable oil.

Visit 3 (duration 3 hours)

After 8 weeks of supplementation, you will attend for a third study visit. This will involve a blood sample and repeating the same measures from the baseline visit with the addition of a measurement of soreness in the upper legs. We will then ask you to complete muscle-damaging exercises consisting of a warm-up of 5 minutes of downhill walking (5% decline at a self selected speed between 3-6 km/h) followed by 4 sets of machine exercises of both leg kicking and leg pushes. These leg exercises will be performed at ~70% of your maximum strength and we will ask you to perform as many repetitions as you can, with the last two sets of each exercise also consisting of 4 extra lowering repetitions. Five minutes and 60 minutes following the muscle-damaging exercise, all the measurements, including blood samples, will be repeated.

Visit 4 (duration 1 hours)

Two days after visit 3, we will once again repeat the measures taken on visit 3 for a final time.

Measurements

Blood sample: A blood sample (15ml) will be collected from a vein in your arm by a trained member of the research team.

Muscle size: We will use an ultrasound to assess muscle thickness of one of the muscles on the outside of your legs.

Muscle strength: You will sit in a chair with your legs at a 90-degree angle. A strap will be placed around the right ankle which will be connected to a force sensor and three sticky surface electrodes will be placed on your thigh. We will then ask you to contract as hard as you can with the leg fixed in position, and we will record the force for 5 seconds. You will perform 3 contractions, with a 1min rest between contractions. After the maximal contractions, will be ask you to contract at 20, 35 and 50% of your maximal effort for 15 seconds so that we can record electrical activity in your muscle. We will then stimulate a contraction with a small electrical current at rest and during a maximal contraction.

We will also measure grip strength, making 3 measures from each hand. We will measure your strength on exercise machines, for both leg kicking and leg pushing. Following a warm-up, the weights on each machine will be progressively increased in until you cannot do any more.

Physical function: We will ask you to rise from a chair 5 times and to walk a distance of 4 metres and record how long this takes. We will also ask you to stand for 10 seconds with your legs in 3 different positions. These will be demonstrated to you before you do this.

Body composition: We will measure total fat and lean mass using bioelectrical impedance analysis.

Soreness: We will ask you to mark on a line how sore your muscle feels to measure muscle soreness before and immediately after the muscle damage protocol in two different tests. In the first test, we will apply a fixed, moderate amount of pressure on your thigh and we will ask you how sore it feels; in the second test, we will apply an increasing amount of pressure until on your thigh until you tell us it feels sore.

Being tested
Krill oil
Keywords
Omega-3, Exercise, Muscle
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Krill oilDietary supplement

    Krill oil supplement

Study groups in NCT06939244
Study groupRoleWhat they receive
Krill oil SupplementExperimental2g of Krill oil per day
Receives: Dietary Supplement: Krill oil
Mixed Vegetable OilPlacebo comparator2g of Mixed Vegetable Oil per day
Receives: Dietary Supplement: Krill oil

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle soreness (Habitual Soreness)

    Visual Analogue Scales will be used to measure muscle soreness before and immediately after the muscle damage protocol. This assessment with a visual analogue scale will be done after asking the participant to sit down and stand up from a chair twice to determine muscle soreness during habitual physical activity.

    Measured: 0 to 48 hours (Post Intervention)

  2. Muscle soreness (Pain Pressure Threshold)

    Visual Analogue Scales will be used to measure muscle soreness before and immediately after the muscle damage protocol. This assessment, with a visual analogue scale and handheld soreness pressure algometer, will determine the pressure threshold required to cause soreness and will be taken at the site which is 10% of the circumference laterally from the mid-point between the iliac crest and the top of the patella.

    Measured: 0 to 48 hours (Post Intervention)

  3. Muscle soreness (5kg/cm2)

    Visual Analogue Scales will be used to measure muscle soreness before and immediately after the muscle damage protocol. This assessment with a visual analogue scale and handheld soreness pressure algometer will be in response to 5kg/cm2 of pressure delivered at 10% of the circumference laterally from the mid-point between the iliac crest and the top of the patella.

    Measured: 0 to 48 hours (Post Intervention)

Secondary outcomes (19)
  1. Fatty Acid Composition

    A venous blood sample (15ml) will be collected by a trained member of the research team from an antecubital vein and analysed for erythrocyte fatty acid profile.

    Measured: From enrollment to the end of treatment at 8 weeks

  2. Muscle size

    We will use ultrasound to assess muscle thickness of the vastus lateralis muscle using B-mode ultrasound with the participants in a supine position. This will also be an indirect measure of muscle damage from cell swelling. The site of the measurement will be 10% of the circumference laterally from the mid-point between the iliac crest and the top of the patella.

    Measured: From enrollment to the end of treatment at 8 weeks

  3. Knee Extensor Strength

    We will measure muscle strength of the knee extensor muscles during a maximal voluntary contraction (MVC) at a 90-degree angle

    Measured: From enrollment to the end of treatment at 8 weeks

  4. Fat mass

    Fat mass will be determined by bioelectrical impedance analysis.

    Measured: From enrollment to the end of treatment at 8 weeks

  5. Grip Strength

    Grip strength will be determined pre- and post the 8-week supplementation period and will be measured with a hand grip dynamometer.

    Measured: From enrollment to the end of treatment at 8 weeks

  6. Gait Speed

    Gait speed will be assessed as a measurement of physical function.

    Measured: From enrollment to the end of treatment at 8 weeks

  7. Balance

    Balance will be assessed by the duration at which they can balance with three separate foot positions

    Measured: From enrollment to the end of treatment at 8 weeks

  8. Chair rise time

    Chair rise time will be assessed by the time it takes for the participant to sit down and sit down 5 times

    Measured: From enrollment to the end of treatment at 8 weeks

  9. Lean Mass

    Lean mass will be determined by bioelectrical impedance analysis.

    Measured: From enrollment to the end of treatment at 8 weeks

  10. Muscle Fiber Conduction Velocity

    Muscle Fiber Conduction Velocity will be assessed by HD-EMG at three different intensities of MVC. 20%, 35% and 50%.

    Measured: From enrollment to the end of treatment at 8 weeks

  11. Voluntary Activation

    Voluntary Activation (VA) is assessed using neuromuscular measurements during muscle strength testing, involving both measurement of force and electrical stimulation of the femoral nerve

    Measured: From enrollment to the end of treatment at 8 weeks

  12. Creatine Kinase

    Creatine Kinase will be assessed by a blood draw prior to, immediately following, 1 hour after and 48 hours after resistance exercise

    Measured: 0 to 48 hours (Post Intervention)

  13. Muscle Size

    We will use ultrasound to assess muscle thickness of the vastus lateralis muscle using B-mode ultrasound with the participants in a supine position. This will also be an indirect measure of muscle damage from cell swelling. The site of the measurement will be 10% of the circumference laterally from the mid-point between the iliac crest and the top of the patella.

    Measured: 0 to 48 hours (Post Intervention)

  14. Knee Extensor Strength

    We will measure muscle strength of the knee extensor muscles during a maximal voluntary contraction (MVC) at a 90-degree angle

    Measured: 0 to 48 hours (Post Intervention)

  15. Gait Speed

    Gait speed will be assessed as a measurement of physical function.

    Measured: 0 to 48 hours (Post Intervention)

  16. Balance

    Balance will be assessed by the duration at which they can balance with three separate foot positions

    Measured: 0 to 48 hours (Post Intervention)

  17. Chair rise time

    Chair rise time will be assessed by the time it takes for the participant to sit down and sit down 5 times

    Measured: 0 to 48 hours (Post Intervention)

  18. Muscle Fiber Conduction Velocity

    Muscle Fiber Conduction Velocity will be assessed by HD-EMG at three different intensities of MVC. 20%, 35% and 50%.

    Measured: 0 to 48 hours (Post Intervention)

  19. Voluntary Activation

    Voluntary Activation (VA) is assessed using neuromuscular measurements during muscle strength testing, involving both measurement of force and electrical stimulation of the femoral nerve

    Measured: 0 to 48 hours (Post Intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2025
  2. Study start1 Feb 2025
  3. Primary completion1 Jul 2025 (estimated)
  4. Study completion1 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06939244
Sponsor's protocol ID
KORE
Acronym
KORE
Status last verified
Mar 2025
First submitted
25 Mar 2025
Last updated
22 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Krill oil in people with Looking at the Effects of Krill Oil Supplementation on Recovery From Muscle-damaging Exercise, run by University of Glasgow at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Stuart Gray (+441413302569, stuart.gray@glasgow.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle soreness (Habitual Soreness) (time frame: 0 to 48 hours (Post Intervention)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in